DYADIC INTERNATIONAL INC Amortization of Debt Issuance Costs
DYADIC INTERNATIONAL INC (DYAI) reported Amortization of Debt Issuance Costs of $14.97 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-12
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for the quarter ending 2026-06-30 was $7.58K, a 36.96% decline year-over-year.
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for the quarter ending 2026-03-31 was $7.38K, a 37.25% decline year-over-year.
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for the quarter ending 2025-12-31 was $12.59K, a 33.93% decline year-over-year.
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for the quarter ending 2025-09-30 was $12.31K, a 28.61% decline year-over-year.
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for fiscal 2025 was $48.70K, a 22.73% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for fiscal 2024 was $63.02K.
- DYADIC INTERNATIONAL INC amortization of debt issuance costs for fiscal 2023 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $14.97K 10-Q · filed 2026-08-12 | $27.56K derived: sum of 3 quarters · filed 2026-08-12 | $39.87K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $7.38K 10-Q · filed 2026-05-13 | $19.97K derived: sum of 2 quarters · filed 2026-05-13 | $32.28K derived: sum of 3 quarters · filed 2026-05-13 | $44.32K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $12.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $24.90K derived: sum of 2 quarters · filed 2026-03-25 | $36.94K derived: sum of 3 quarters · filed 2026-08-12 | $48.70K 10-K · filed 2026-03-25 |
| 2025-09-30 | $12.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $24.34K derived: sum of 2 quarters · filed 2026-08-12 | $36.10K 10-Q · filed 2025-11-12 | $55.16K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $12.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $23.79K 10-Q · filed 2026-08-12 | $42.85K derived: sum of 3 quarters · filed 2026-08-12 | $60.10K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $11.76K 10-Q · filed 2026-05-13 | $30.82K derived: sum of 2 quarters · filed 2026-05-13 | $48.07K derived: sum of 3 quarters · filed 2026-05-13 | $71.66K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $19.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $36.30K derived: sum of 2 quarters · filed 2026-03-25 | $59.90K derived: sum of 3 quarters · filed 2026-03-25 | $63.02K 10-K · filed 2026-03-25 |
| 2024-09-30 | $17.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $40.84K derived: sum of 2 quarters · filed 2025-11-12 | $43.96K 10-Q · filed 2025-11-12 | $43.96K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $23.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $26.72K 10-Q · filed 2025-08-13 | $26.72K derived: sum of 3 quarters · filed 2025-08-13 | $26.72K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.13K 10-Q · filed 2025-05-14 | $3.13K derived: sum of 2 quarters · filed 2025-05-14 | $3.13K derived: sum of 3 quarters · filed 2025-05-14 | $3.13K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $0.00 10-K · filed 2025-03-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |